Bicycle Therapeutics Plc ADR
(BCYC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,534 | -16,259 |
| Depreciation Amortization | 166 | 332 |
| Accounts receivable | -1,671 | N/A |
| Accounts payable and accrued liabilities | -394 | N/A |
| Other Working Capital | -5,195 | 13,022 |
| Other Operating Activity | 2,355 | 1,490 |
| Operating Cash Flow | $-7,273 | $-1,415 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -264 | -1,113 |
| Investing Cash Flow | $-264 | $-1,113 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 0 | 57,876 |
| Financing Cash Flow | $N/A | $57,876 |
| Exchange Rate Effect | 2,432 | 2,913 |
| Beginning Cash Position | 67,663 | 9,402 |
| End Cash Position | 62,558 | 67,663 |
| Net Cash Flow | $-5,105 | $58,261 |
| Free Cash Flow | ||
| Operating Cash Flow | -7,273 | -1,415 |
| Capital Expenditure | -264 | N/A |
| Free Cash Flow | -7,537 | -1,415 |